Yeh, Chung-Yang
Chini, Lucas C. S.
Davidson, Jessica W.
Garcia, Gonzalo G.
Gallagher, Meredith S.
Freichels, Isaac T.
Calubag, Mariah F.
Rodgers, Allison C.
Green, Cara L.
Babygirija, Reji
Sonsalla, Michelle M.
Pak, Heidi H.
Trautman, Michaela E.
Hacker, Timothy A.
Miller, Richard A. https://orcid.org/0000-0001-9266-9649
Simcox, Judith A.
Lamming, Dudley W. https://orcid.org/0000-0002-0079-4467
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG056771, AG062328, AG081482, AG084156, and AG085898, T32AG000213, AG077916, AG084921, AG082504, AG081115, AG066311, AG083290)
Glenn Foundation for Medical Research
Hevolution Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK133479)
Article History
Received: 9 January 2024
Accepted: 10 October 2024
First Online: 27 November 2024
Competing interests
: D.W.L. has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases. The other authors declare no competing interests.